RJ Reynolds Topic List
|
|
|
- Karin Sparks
- 6 years ago
- Views:
Transcription
1 RJ Reynolds Topic List ADVERTISEMENTS AMMONIA USE ARTICLES OF INCORPORATION/BY-LAWS BILLBOARD PLACEMENT LOCATION BIOLOGICAL ACTIVITY OF CIGARETTES BIOLOGICAL RESEARCH DIVISION BOARD OF DIRECTORS MEETINGS CIAR (CENTER FOR INDOOR AIR RESEARCH) COMPANY WEBSITES CONSUMER VIEWS REGARDING "TAR" AND NICOTINE LEVELS CTR SPECIAL PROJECTS CTR/TIRC DIRECT MARKETING DOCUMENT RETENTION ECLIPSE Primarily published advertisements for R.J. Reynolds' marketed cigarette products. Documents that discuss or relate to the alleged effect of ammonia on nicotine delivery, nicotine transfer rate, or bioavailability of nicotine. R.J. Reynolds Tobacco Company articles of incorporation and bylaws, and amendments to by-laws. Documents that discuss or relate to allegations regarding whether or not billboards were placed near primary schools, middle schools, high schools, or playgrounds. Documents that discuss or relate to biological activity, including toxicological or mutagenicity testing, related to cigarettes or the components or constituents of cigarettes or cigarette smoke. This topic also includes documents concerning the comparison of the biological activity of different brands or styles of cigarettes. Documents that discuss or relate to the R.J. Reynolds Biological Research Division that was formed in 1965 and operated through March 29, 1970, and includes documents concerning research performed by the Biological Research Division. Documents generated by, prepared for, reviewed by, or received by the R.J. Reynolds Tobacco Company Board of Directors, including minutes of the meetings of the Board of Directors and the Executive Committee of R.J. Reynolds Tobacco Company. Documents that discuss or relate to the establishment of CIAR or research performed on behalf of CIAR. Documents that discuss or relate to R.J. Reynolds' publicly available corporate website at or other R.J. Reynolds publicly available websites. Documents that discuss or relate to consumers' perceptions concerning the levels of "tar" and nicotine in cigarettes. Documents that discuss or relate to projects funded through the Council for Tobacco Research as "Special Projects." Documents that discuss or relate to the Council for Tobacco Research or the Tobacco Industry Research Committee. Documents that discuss or relate to the marketing of cigarettes through mailings or other communications made directly to adult smokers over 21. Documents that discuss or relate to the retention of R.J. Reynolds' documents, including retention policies or schedules. Documents that discuss or relate to the research, development, and/or marketing of Eclipse cigarettes.
2 EDITORIAL ADVERTISEMENTS EFFECTS OF ADVERTISING EFFORTS TO DISCOURAGE UNDERAGE SMOKING ELECTRONIC MEDIA AND MOTION PICTURES ENVIRONMENTAL TOBACCO SMOKE (ETS) CONDUCTED AT R.J. REYNOLDS RESEARCH ENVIRONMENTAL TOBACCO SMOKE (ETS) SPONSORED RESEARCH EVENT SPONSORSHIP FTC - SPECIAL REPORTS HEALTH CARE COSTS HEALTH INSURANCE RATES INDUSTRY COMMITTEES Documents that discuss or relate to R.J. Reynolds' public issue advertisements, including copies of the advertisements and documents concerning the placement of public issue advertisements, such as: "Is The Government Going Too Far." Documents that discuss or relate to the effects, or alleged effects, of cigarette advertising upon the public, including whether cigarette advertising has an impact on the initiation, continuation, cessation or amount of smoking or switching among brands. Documents that discuss or relate to R.J. Reynolds or tobacco industry efforts to prevent or discourage persons under the age of 18 from smoking. Documents that discuss or relate to the use of television or radio prior to 1971 to carry cigarette advertising; documents discussing or related to television or radio coverage of events sponsored by R.J. Reynolds; or documents discussing or related to allegations concerning placing cigarette products in or refusing to provide products for placement in motion pictures. Documents that discuss or relate to R.J. Reynolds' in-house research concerning the measurement of ETS, exposure to ETS, or alleged health consequences of ETS. Documents that discuss or relate to research concerning the measurement of ETS, exposure to ETS, or alleged health consequences of ETS performed by persons or entities other than R.J. Reynolds which research was supported or funded by R.J. Reynolds or organizations such as Center for Indoor Air Research (CIAR) which received funding from R.J. Reynolds. Documents that discuss or relate to sporting events or other special events sponsored by R.J. Reynolds, including allegations regarding whether signs or advertising materials at such events were seen or not seen on television. Documents that discuss or relate to annual reports submitted by R.J. Reynolds to the FTC that reflect, among other things: expenditures for marketing and promotion of cigarettes, the number of cigarettes sold, and the "tar" and nicotine yields in cigarettes. Documents that discuss or relate to alleged health care costs for smokers, including documents that discuss the alleged costs of health care for non-smokers versus the costs of health care for smokers. Documents that discuss or relate to health insurance rates for smokers, including documents that discuss the health insurance rates for nonsmokers versus the health insurance rates for smokers. Documents that discuss or relate to various tobacco industry related committees including the Industry Research Committee, Industry Technical Committee, Scientific Advisory Board, Scientific Advisory Committee, Ad Hoc Committee, Research Liaison Committee,
3 Committee of Counsel, Communications Committee and Cigarette Advertising Code. INDUSTRY/COMPANY GUIDELINES CONCERNING MARKETING TO PERSONS UNDER SPECIFIED AGES INSURANCE POLICIES JOE CAMEL DOCUMENTS LAWYER SPECIAL ACCOUNTS MAGAZINE READERSHIP MARKET SEGMENTS MARKETING POLICIES MARKETING RESEARCH MARKETING STRATEGY MASTER SETTLEMENT AGREEMENT (MSA) COMPLIANCE AND IMPACT NICOTINE AND ADDICTION Documents that discuss or relate to any R.J. Reynolds or tobacco industry guidelines concerning advertising, promoting, or marketing to persons under specified ages or marketing research involving persons under specified ages. Insurance policies and related documents that have been produced for review to assess potential coverage for liability arising from claims regarding the health effects or marketing of cigarettes, and documents relating to considerations of self-insuring for such claims. Documents that discuss or relate to the "Joe Camel" advertising campaign, including advertisements, marketing documents, and documents concerning studies or surveys on the effect of "Joe Camel" on minors. Documents that discuss or relate to lawyer special accounts, including special accounts 4 and 5 and Shook, Hardy & Bacon special account. Documents that discuss or relate to magazine readership in general, the age or characteristics of persons who read or subscribe to particular magazines, or the editorial content or "target" market of particular magazines. Documents that discuss or relate to marketing, advertising or marketing research that relates to or has been alleged to relate to specific market segments, including: blue collar workers, ethnic groups, females and the military. Documents that discuss or relate to R.J. Reynolds policies concerning marketing of its products. Documents that discuss or relate to marketing research. Documents that primarily concern marketing research but also reflect R.J. Reynolds' marketing strategy are categorized to this topic. Documents that discuss or relate to R.J. Reynolds' marketing strategy or plans for marketing or advertising cigarettes. Documents that primarily concern R.J. Reynolds' marketing strategy or plans but also reflect marketing research are categorized to this topic. Documents that (1) discuss or relate to compliance by R.J. Reynolds or other tobacco industry entities with the terms of the MSA or the terms of separate settlement agreements with the states of Florida, Minnesota, Mississippi, or Texas or (2) discuss or relate to (a) the economic effects of the MSA or any of the separate settlement agreements with the states of Florida, Minnesota, Mississippi, or Texas; or (b) any changes or contemplated changes by R.J. Reynolds or the tobacco industry in marketing or pricing as a result of those settlements. Documents that discuss or relate to the alleged addictive or habit forming nature of cigarette use; documents that reflect research
4 concerning the effects of nicotine, nicotine pharmacology, smoking cessation, or any relationship between smoker satisfaction and nicotine and documents that discuss or relate to research on the nicotine content, levels, or delivery of cigarettes. ORGANIZATION CHARTS PATENTS PREMIER PRESS RELEASES PUBLIC STATEMENTS OTHER THAN PRESS RELEASES RESEARCH CONDUCTED AT R.J. REYNOLDS REGARDING THE HEALTH CONSEQUENCES OF SMOKING "SAFER" CIGARETTE SMOKER ATTITUDES RE: SMOKING AND HEALTH HAZARDS AND ADDICTION SMOKER COMPENSATION SMOKING AND ASBESTOS SMOKING AND BLADDER SMOKING AND R.J. Reynolds organization charts. Documents that discuss or relate to patents or patent applications of R.J. Reynolds. Documents that discuss or relate to the research, development, test marketing, or withdrawal from test market of Premier. Documents that discuss or relate to press releases issued by R.J. Reynolds, RJR Nabisco, or any trade associations (such as the Tobacco Institute) which possibly concern smoking and health. Documents that discuss or relate to public or published statements by R.J Reynolds which concern smoking and health, the addictiveness or lack of addictiveness of smoking, smoker compensation, or "tar" or nicotine delivery of cigarettes. Documents that discuss or relate to research conducted "in-house" by R.J. Reynolds concerning or related to health consequences of smoking. Research includes, but is not limited to: Ames testing and other mutagenicity testing; research on tobacco substitutes; animal research; research concerning identification of constituents of tobacco or tobacco smoke; research concerning extraction or reduction of constituents; and toxicological research. Documents that discuss or relate to the attempted development of a "safer" cigarette, including, but not limited to, research on the use of "catalysts" in cigarettes, documents relating or referring to whether or not to market a "safer" cigarette and documents relating to statements to make or not make in the marketing of "safer" cigarettes. Includes documents that possibly relate to the research, development, or marketing of Eclipse or Premier cigarettes. Documents that discuss or relate to smokers' perceptions, attitudes, reactions, or psychology in regards to claims concerning the health hazards or addictiveness of cigarettes. Documents that discuss or relate to smoking behaviors that are claimed to compensate for lower levels of nicotine in cigarettes. Documents that discuss or relate to the effect of smoking/exposure to tobacco smoke together with exposure to asbestos. relationship between smoking and bladder cancer. This topic is focused on a particular form of cancer instead of cancer in general. relationship between smoking and cancer, including, but not limited to, lung cancer, oral cancer, cancer of the pharynx, cancer of the larynx,
5 cancer of the trachea, cancer of the esophagus, and bladder cancer. SMOKING AND CIRCULATORY DISEASES SUCH AS ARTERIOSCLEROSIS/STROKE SMOKING AND EMPHYSEMA/COPD SMOKING AND ESOPHAGEAL SMOKING AND HEART DISEASE SMOKING AND LARYNGEAL SMOKING AND LUNG SMOKING AND ORAL SMOKING AND PHARYNGEAL SMOKING AND TRACHEAL SPONSORED RESEARCH ON SMOKING AND HEALTH STATEMENTS RE: SMOKING AND ADDICTION relationship between cigarette smoking or passive smoking and circulatory diseases such as stroke, arteriosclerosis, or Buerger's Disease. This topic focuses on circulatory diseases other than heart disease. Documents related to heart disease, as opposed to other circulatory diseases, are categorized to the "Smoking and Heart Disease" topic. relationship between smoking and emphysema or chronic obstructive pulmonary disease. relationship between smoking and esophageal cancer. This topic focuses on a particular form of cancer instead of cancer in general. relationship between smoking and heart disease. This topic focuses on heart disease instead of other circulatory diseases. Documents related to other circulatory diseases, as opposed to heart disease, are categorized to the "Smoking and Circulatory Diseases such as Arteriosclerosis/Stroke" topic. relationship between smoking and laryngeal cancer. This topic focuses on a particular form of cancer instead of cancer in general. relationship between smoking and lung cancer. relationship between smoking and oral cancer. This topic focuses on a particular form of cancer instead of cancer in general. relationship between smoking and pharyngeal cancer. This topic focuses on a particular form of cancer instead of cancer in general. relationship between smoking and tracheal cancer. This topic focuses on a particular form of cancer instead of cancer in general. Documents that discuss or relate to research on smoking and health issues that was performed by persons or entities other than R.J. Reynolds and that was sponsored or funded by R.J. Reynolds or by organizations, such as the Council for Tobacco Research, which received funding from R.J. Reynolds. Documents concerning research conducted by R.J. Reynolds are categorized to the "Research Conducted In-House" at R.J. Reynolds Regarding the Health Consequences of Smoking" topic. Documents that discuss or relate to R.J. Reynolds' or the tobacco industry's position regarding whether or not smoking and/or nicotine is
6 addictive. STATEMENTS RE: SMOKING AND DISEASE SWITCHING TOBACCO INDUSTRY ORGANIZATIONS OTHER THAN CTR/TI TOBACCO INSTITUTE TOBACCO SMOKE CONSTITUENTS UNDERAGE SMOKING WARNINGS YOUNG ADULT SMOKING Documents that discuss or relate to R.J. Reynolds' or the tobacco industry's position regarding whether or not smoking causes disease. Documents discussing or related to the number or percentage of smokers who switch cigarette brands. Documents that discuss or relate to R.J. Reynolds' involvement in tobacco related organizations other than the Council for Tobacco Research, Tobacco Industry Research Committee or the Tobacco Institute. Documents that discuss or relate to the Tobacco Institute. Documents that discuss or relate to the constituents and compounds found in cigarette smoke, including, but not limited to, "tar," nicotine, carbon monoxide, nitrosamines, acetaldehyde, benzoapyrene, and phenols. Documents pertaining to allegations regarding marketing and advertising directed at persons under the age of 18 and allegations regarding research pertinent to smoking by persons under the age of 18. Includes documents that refer to persons under the age of 18 and in some manner also concern smoking incidence, marketing, advertising, or marketing research. This topic provides documents that might be deemed to be related to allegations concerning underage smoking without regard to whether the references to or discussions of persons under the age of 18 in particular documents were related to marketing, advertising, or marketing research. Documents that discuss or relate to the effectiveness of the warnings of packages of cigarettes or cigarette advertising, or concerning or relating to other issues involving health warnings, including, but not limited to, proposals for warnings. Documents that discuss or relate to marketing or advertising to persons 18 through 24 years old, or marketing research involving persons 18 through 24 years old.
Who is Targeting You? The Tobacco Industry Those who want to profit from your smoking
Who is Targeting You? The Tobacco Industry Those who want to profit from your smoking The Tobacco Industry like no other Tobacco is the ONLY legal product sold that is lethal when used exactly as the manufacturer
Country profile. Timor-Leste
WHO Report on the Global Tobacco Epidemic, 2013 Country profile Timor-Leste WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 25 May 2004 Date of ratification (or legal equivalent)
Country profile. Myanmar
WHO Report on the Global Tobacco Epidemic, 2013 Country profile Myanmar WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 23 October 2003 Date of ratification (or legal equivalent)
Country profile. Lebanon
WHO Report on the Global Tobacco Epidemic, 2013 Country profile Lebanon WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 4 March 2004 Date of ratification (or legal equivalent)
Country profile. Nepal
WHO Report on the Global Tobacco Epidemic, 2013 Country profile Nepal WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 3 December 2003 Date of ratification (or legal equivalent)
Country profile. Gambia. Note: Where no data were available, " " shows in the table. Where data were not required, " " shows in the table.
WHO Report on the Global Tobacco Epidemic, 2011 Country profile Gambia te: Where no data were available, " " shows in the table. Where data were not required, " " shows in the table. WHO Framework Convention
Country profile. Cuba
Country profile Cuba WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 29 June 2004 Date of ratification (or legal equivalent) t ratified Socioeconomic context Population
Country profile. Senegal
Country profile Senegal WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 19 June 2003 Date of ratification (or legal equivalent) 27 January 2005 Socioeconomic context Population
Country profile. Poland
Country profile Poland WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 14 June 2004 Date of ratification (or legal equivalent) 15 September 2006 Socioeconomic context Population
Country profile. Angola
Country profile Angola WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 29 June 2004 Date of ratification (or legal equivalent) 20 September 2007 Socioeconomic context Population
Lao People's Democratic Republic
Country profile Lao People's Democratic Republic WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 29 June 2004 Date of ratification (or legal equivalent) 6 September 2006
Country profile. Turkmenistan. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent) 13 May 2011
Country profile Turkmenistan WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature t signed Date of ratification (or legal equivalent) 13 May 2011 Socioeconomic context Population
Maryland Study Joe Camel more recognizable to 6-year-olds
1 Tobacco and Health Hazards by Kathleen Kiem Hoa Oey Kuntaraf, M.D., M.P.H. Associate Director for Prevention General Conference of Seventh-day Adventists 2 3 4 5 Maryland Study Joe Camel more recognizable
Country profile. Gambia
Country profile Gambia WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 18 September 2007 Socioeconomic context Population
Country profile. Brazil
Country profile Brazil WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 3 vember 2005 Socioeconomic context Population
Country profile. Trinidad and Tobago
Country profile Trinidad and Tobago WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 27 August 2003 Date of ratification (or legal equivalent) 19 August 2004 Socioeconomic
Smoking Harm Reduction: If Not Now When?
Smoking Harm Reduction: If Not Now When? K. Michael Cummings, PhD, MPH Medical University of South Carolina The E-Cigarette Summit Washington DC, April 30, 2018 Outline for my talk Historical context,
Country profile. Bahrain. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent) 20 March 2007
Country profile Bahrain WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature t signed Date of ratification (or legal equivalent) 20 March 2007 Socioeconomic context Population
Country profile. Hungary
Country profile Hungary WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 7 April 2004 Socioeconomic context Population
Country profile. Chad
Country profile Chad WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 22 June 2004 Date of ratification (or legal equivalent) 30 January 2006 Socioeconomic context Population
Country profile. Italy
Country profile Italy WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 2 July 2008 Socioeconomic context Population
Country profile. Sweden
Country profile Sweden WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 7 July 2005 Socioeconomic context Population
Country profile. Austria
Country profile Austria WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 28 August 2003 Date of ratification (or legal equivalent) 15 September 2005 Socioeconomic context
Country profile. Ukraine
Country profile Ukraine WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 25 June 2004 Date of ratification (or legal equivalent) 6 June 2006 Socioeconomic context Population
Country profile. Republic of Moldova
Country profile Republic of Moldova WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 29 June 2004 Date of ratification (or legal equivalent) 3 February 2009 Socioeconomic
United Kingdom of Great Britain and Northern Ireland
Country profile United Kingdom of Great Britain and rthern Ireland WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent)
Country profile. New Zealand
Country profile New Zealand WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 27 January 2004 Socioeconomic context
Bosnia and Herzegovina
Country profile Bosnia and Herzegovina WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature t signed Date of ratification (or legal equivalent) 10 July 2009 Socioeconomic context
Country profile. Yemen
Country profile Yemen WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 20 June 2003 Date of ratification (or legal equivalent) 22 February 2007 Socioeconomic context Population
Country profile. Egypt
Country profile Egypt WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 17 June 2003 Date of ratification (or legal equivalent) 25 February 2005 Socioeconomic context Population
Country profile. Russian Federation. WHO Framework Convention on Tobacco Control (WHO FCTC) status
Country profile Russian Federation WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature t signed Date of ratification (or legal equivalent) 3 June 2008 Socioeconomic context
Country profile. Switzerland
Country profile Switzerland WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 25 June 2004 Date of ratification (or legal equivalent) t ratified Socioeconomic context Population
Country profile. Canada
Country profile Canada WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 15 July 2003 Date of ratification (or legal equivalent) 26 vember 2004 Socioeconomic context Population
Country profile. Norway
Country profile rway WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 16 June 2003 Socioeconomic context Population
Country profile. Morocco
Country profile Morocco WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 April 2004 Date of ratification (or legal equivalent) t ratified Socioeconomic context Population
Research Study: Court-Ordered Corrections of Tobacco Industry Racketeering PRELIMINARY REPORT Background Methods Results Conclusions
Research Study: Court-Ordered Corrections of Tobacco Industry Racketeering National Poll Shows Support for Policies, Lawmakers Rejection of Tobacco Industry Influences PRELIMINARY REPORT Background Internal
ACTION PLAN. Intergovernmental Coordinating Body, Ministry of Finance. Intergovernmental Coordinating Body, Ministry of Finance
ACTION PLAN Strategic goal 1: Reduction of tobacco demand which should reduce the prevalence of smoking in the population Objectives Activity/Action Responsible Party/Implementing Body Deadline Source
Country profile. Colombia. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent) 10 April 2008
Country profile Colombia WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature t signed Date of ratification (or legal equivalent) 10 April 2008 Socioeconomic context Population
Iran (Islamic Republic of)
Country profile Iran (Islamic Republic of) WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 16 June 2003 Date of ratification (or legal equivalent) 6 November 2005 Socioeconomic
Country profile. Guinea
Country profile Guinea WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature 1 April 2004 Date of ratification (or legal equivalent) 7 vember 2007 Socioeconomic context Population
Country profile. Indonesia. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent)
Country profile Indonesia WHO Framework Convention on Tobacco Control (WHO FCTC) status Date of signature Date of ratification (or legal equivalent) t signed t ratified Socioeconomic context Population
EXECUTIVE SUMMARY. 1 P age
EXECUTIVE SUMMARY The Global Adult Tobacco Survey (GATS) is the global standard for systematically monitoring adult tobacco use (smoking and smokeless) and tracking key tobacco control indicators. GATS
Communicating the Risk of Nicotine Delivery Products
Communicating the Risk of Nicotine Delivery Products August 10, 2014 ACS National Meeting Jim Solyst June 24, 2014 1 Nicotine Background Key Points The popularity of e-cigarettes has increased the need
NCDs Risk Factor No. 3 - Smoking. Commonwealth Nurses Federation
NCDs Risk Factor No. 3 - Smoking Commonwealth Nurses Federation Overview Definition of smoking and passive smoking Complications associated with smoking Disease process of smoking Reasons for smoking The
MARKETING STANDARDS FOR MEMBERSHIP
MARKETING STANDARDS FOR MEMBERSHIP The Vapor Technology Association (VTA) is a leading national trade association in the electronic cigarette and vapor product industry. VTA represents the manufacturers,
Global Adult Tobacco Survey TURKEY. Dr. Peyman ALTAN MoH Tobacco Control Dep. Ankara November 2018
Global Adult Tobacco Survey TURKEY Dr. Peyman ALTAN MoH Tobacco Control Dep. Ankara November 2018 GATS Objectives GATS was launched as part of the Global Tobacco Surveillance System (GTSS) and it was first
Appendix III - Tobacco Settlement Summary
Journal of Health Care Law and Policy Volume 2 Issue 1 Article 11 Appendix III - Tobacco Settlement Summary Follow this and additional works at: http://digitalcommons.law.umaryland.edu/jhclp Recommended
TOBACCO SMOKING (CONTROL) ACT
TOBACCO SMOKING (CONTROL) ACT ARRANGEMENT OF SECTIONS 1. Control of tobacco smoking. 2. Restriction on tobacco smoking advertisement. 3. Tobacco packages to contain certain information. 4. Penalties for
- Decree nº (January 2 nd, 2006) Promulgates the Framework Convention on Tobacco Control
Brazilian Federal Legislation on Tobacco Control 3.1.1 General obligations - Decree (August 1 st, 2003) Creates the National Commission for the Implementation of the Framework Convention on Tobacco Control.
Tobacco Control. (Update 2008)
Tobacco Control (Update 2008) CMA POLICY Tobacco is an addictive and hazardous product, and the number one cause of preventable disease and death in Canada. Canada s physicians, who see the devastating
Rationale for Establishing Tobacco Product Regulation
Rationale for Establishing Tobacco Product Regulation Erik Dybing, MD, PhD Conference of the Parties Technical Briefing Geneva, 7 February 2006 WHO Strategy for Tobacco Control Preventing uptake of tobacco
APPENDIX V: COUNTRY PROFILES
WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2011 APPENDIX V: COUNTRY PROFILES Argentina Bangladesh Brazil China Egypt France Germany India Indonesia Iran (Islamic Republic of) Italy Japan Mexico Myanmar
CDC and Bridging the Gap: Introducing New State Appropriation, Grants, and Expenditure Data in the STATE System
CDC and Bridging the Gap: Introducing New State Appropriation, Grants, and Expenditure Data in the STATE System Frank Chaloupka, PhD (University of Illinois-Chicago) Jidong Huang, PhD (University of Illinois-Chicago)
Menthol Cigarette Report
Menthol Cigarette Report Tobacco Products Scientific Advisory Committee Meeting July 15, 2010 Corinne G. Husten, MD, MPH Senior Medical Advisor Center for Tobacco Products, FDA 1 Menthol Cigarette Report
GATS Highlights. GATS Objectives. GATS Methodology
GATS Objectives GATS Highlights The Global Adult Tobacco Survey (GATS) is a global standard for systematically monitoring adult tobacco use (smoking and smokeless) and tracking key tobacco control indicators.
WHO Framework Convention on Tobacco Control
WHO Framework Convention on Tobacco Control When WHO was established in 1948, its Member States incorporated the power to negotiate treaties into its Constitution. This power remained dormant until 1996,
Smoking vs Smokeless. Tobacco is a plant that contains nicotine. Cigars and pipes contain more tar and other chemicals.
Tobacco Smoking vs Smokeless Tobacco is a plant that contains nicotine. Cigars and pipes contain more tar and other chemicals. Smoking Tobacco is tobacco that is smoked or inhaled. Smokeless tobacco is
COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 23.11.2009 SEC(2009) 1621 final COMMISSION STAFF WORKING DOCUMENT Report on the implementation of the Council Recommendation of 2 December 2002 on the prevention
There is no such thing as a safe cigarette, and no safe level of exposure to the carcinogens or other toxic substances contained in tobacco smoke.
POSITION STATEMENT Dangers of reduced-harm cigarettes Smokers considering changing to so-called reduced harm cigarettes should not conclude that these products are a less harmful alternative Key messages
Where We Are: State of Tobacco Control and Prevention
Where We Are: State of Tobacco Control and Prevention Corinne Husten, MD, MPH Acting Director CDC Office on Smoking and Health Nova Scotia, Canada October 2006 Tobacco Impact Background Tobacco is leading
G O V E R N M E N T N O T I C E S G O E W E R M E N T S K E N N I S G E W I N G S
STAATSKOERANT, 29 SEPTEMBER 2000 No. 21610 p.5 G O V E R N M E N T N O T I C E S G O E W E R M E N T S K E N N I S G E W I N G S DEPARTMENT OF HEALTH DEPARTMENT VAN GESONDHEID No. R. 974 29 September 2000
NIIPAITAPIIYSSIN: Tobacco in Indian Country. Two Tobacco Ways in Indian Country
NIIPAITAPIIYSSIN: Tobacco in Indian Country Minnesota and Wisconsin American Indian Cancer Conference October 24, 2008 Two Tobacco Ways in Indian Country 1. Traditional tobacco use honors the Creator and
LAW OF MONGOLIA. 01 July, Ulaanbaatar, Mongolia LAW ON TOBACCO CONTROL CHAPTER ONE GENERAL PROVISIONS
LAW OF MONGOLIA 01 July, 2005. Ulaanbaatar, Mongolia LAW ON TOBACCO CONTROL Article 1: The Purpose Of The Law CHAPTER ONE GENERAL PROVISIONS 1.1 The purpose of this law is to define the legal framework
SUMMARY OF THE MASTER SETTLEMENT AGREEMENT (MSA)
SUMMARY OF THE MASTER SETTLEMENT AGREEMENT (MSA) The Master Settlement Agreement (MSA) between the states and the major U.S. tobacco companies will direct a lot of money to the states, but it says nothing
Government Gazette REPUBLIC OF SOUTH AFRICA
Government Gazette REPUBLIC OF SOUTH AFRICA Vol. 523 Cape Town 9 January 2009 No. 31790 THE PRESIDENCY No. 23 9 January 2009 It is hereby notified that the President has assented to the following Act,
Social and Policy Perspective on Tobacco Use
Social and Policy Perspective on Tobacco Use Kenneth E. Warner University of Michigan School of Public Health National Cancer Policy Forum Workshop on Reducing Tobacco-Related Cancer Incidence and Mortality
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA R.J. REYNOLDS TOBACCO CO., et al., v. Plaintiffs, No. 1:11-cv-1482 (RJL) UNITED STATES FOOD AND DRUG ADMINISTRATION, et al., Defendants. UNOPPOSED
August University Enforcing Campus Clean Air Act. Smoking on campus is illegal under new state law
Office of Environmental Health and Safety University of Arkansas 521 S. Razorback Road Dr. Miriam Lonon, Manager 575-3597 Michelle Depperschmidt, Secretary 575-5448 Hillary Booth, Occupational Safety Coordinator
DECISION. Recalling further its decision FCTC/COP5(6) to adopt further partial guidelines;
66 Conference of the Parties to the WHO Framework Convention on Tobacco Control Seventh session Delhi, India, 7 12 November 2016 12 November 2016 DECISION FCTC/COP7(14) Further development of the partial
World no tobacco day. Narayana Medical Journal Vol 1: Issue 2. Review: Gowrinath K. Published online: Oct 2012
Narayana Medical Journal Vol 1: Issue 2 Review: World no tobacco day Gowrinath K Published online: Oct 2012 Tobacco smoking is the single most important preventable cause of sickness and premature death.
Use all articles listed
You're a doctor, and a new patient comes into your office. She admits to being a smoker. It's your job to inform her of the health hazards related to smoking. Describe below the health hazards related
Mali. Report card on the WHO Framework Convention on Tobacco Control. 17 January Contents. Introduction. Mali entry into force of the WHO FCTC
Report card on the WHO Framework Convention on Tobacco Control Mali Introduction Tobacco use is the single most preventable cause of death in the world today, and is estimated to kill more than five million
DIGGING INTO TOBACCO DOCUMENTS
DIGGING INTO TOBACCO DOCUMENTS Real Life Examples of How to Advance Tobacco Control August 7, 2012 Public Health Policy Change Webinar Series Providing substantive public health policy knowledge, competencies
Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement
Claims about health in ads for e-cigarettes CAP and BCAP s regulatory statement Contents 1. Executive Summary... 2 2. Policy background and the decision to consult... 4 3. Decisions... 6 4. Consequence
TOBACCO PRODUCT OR MEDICAL PRODUCT?
TOBACCO PRODUCT OR MEDICAL PRODUCT? Priscilla Callahan-Lyon, MD Deputy Director Division of Individual Health Science Office of Science, CTP Grail Sipes, JD Director Office of Regulatory Policy, CDER Disclaimer:
Selected Agent Characteristics. Product type Nicotine dose levels Constituents (e.g., tar, CO) and ingredients (e.g., additives) Market share
Tobacco Measurement Stephen Marcus, Ph.D. Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences Public Health Model Agent -- tobacco products
TOBACCO USE AMONG AFRICAN AMERICANS
TOBACCO USE AMONG AFRICAN AMERICANS Each year, approximately 45,000 African Americans die from smoking-related disease. 1 Smoking-related illnesses are the number one cause of death in the African-American
Submission to the World Health Organization on the Global Tobacco Control Committee
Submission to the World Health Organization on the Global Tobacco Control Committee Massachusetts Coalition For a Healthy Future Gregory N. Connolly, D.M.D., M.P.H. 250 Washington Street, 4 th Floor Boston,
Problem Which option Additional option Additional comments definition Yes No change No further observations.
Department of Health, United Kingdom electronic contribution rec. 317 - by Mr Lee McGill lee.mcgill@dh.gsi.gov.uk Question 1 - scope Problem Which option Recommend option Additional comments Yes No change
Definition of Drug. an article (other than food) intended to affect the structure or any function of the body. Sections 201 (g)(1)(c)
Definition of Drug an article (other than food) intended to affect the structure or any function of the body Sections 201 (g)(1)(c) Increase Nicotine Content by Adding Nicotine to Filters, Wrappers, etc.
Cigarettes. Ada Ellisman, Bryan Gibson, & Evie White
Cigarettes Ada Ellisman, Bryan Gibson, & Evie White Problems Smoking can cause cancer in various parts in the human body. It affects nearly every organ and the person s well being It increases the risk
Get Your Facts Straight!
Survey ID: Date: Get Your Facts Straight! True or False? DIRECTIONS: Write a T for True or an F for False by each statement. 1) 2) 3) 4) 5) 6) 7) 8) 9) Most teens in South Carolina smoke. Smokeless tobacco
Align your brand with one of education s most highly respected and experienced organizations.
Christian Schools International Sponsorship Opportunities 2014-2015 Align your brand with one of education s most highly respected and experienced organizations. Sponsorship Opportunities Join Us. Founded
Reduced Risk Review March Keith Lenghaus
Reduced Risk Review March 2005 Keith Lenghaus Reducing Exposure Add filters (1950s) Rapid gain in market share Reduce tar, nicotine (1960s on) FTC method Competitive advantage Advertising Pollay et al
Peter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013
Peter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013 Conceptual Framework for Evaluating MRTPs: Objectives Provide a framework for evaluating all tobacco products
consistent with the industry documents we note in our September letter.
February 18, 2010 Division of Dockets Management (HFA-305) Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane, Room 1061 Rockville, MD 20852 RE: Docket Number FDA-2010-N-0020
TFI WHO 20 Avenue Appia 1211 Geneva 27, Switzerland. Gentlemen:
Donald D. Foreman, Director Federal Government Affairs 1455 Pennsylvania Avenue, NW, Suite 925 Washington, DC 20004 Telephone: (202) 626-7200 Fax: (202) 626-7208 TFI WHO 20 Avenue Appia 1211 Geneva 27,
Uganda. Report card on the WHO Framework Convention on Tobacco Control. 18 September Contents. Introduction
Report card on the WHO Framework Convention on Tobacco Control Uganda Introduction Tobacco use is the single most preventable cause of death in the world today, and is estimated to kill more than five
Colleges For Change Mobilizing the College Community to Take Action Against Big Tobacco
Colleges For Change Mobilizing the College Community to Take Action Against Big Tobacco Presented by the Coordinators of Colleges for Change October 22, 2010 Agenda Introductions New York State Department
DRAFT FOR CONSULTATION
DRAFT FOR CONSULTATION Member s Bill Explanatory note General policy statement Smoking rates and tobacco consumption have declined in recent decades. However, 4 500 to 5 000 New Zealanders still die prematurely
REPORTING INSTRUMENT
REPORTING INSTRUMENT 1. Origin of the report (a) Name of Contracting Party JAPAN (b) Information on National Contact/Focal Point Name and title of contact officer Hidenori Yamamoto, M.D., PH.D., Deputy-
TRENDS IN TOBACCO INDUSTRY MARKETING
TRENDS IN TOBACCO INDUSTRY MARKETING In the November 1998 multi-state Master Tobacco Settlement Agreement (MSA), the major cigarette companies and U.S. Smokeless Tobacco, Inc. (the biggest smokeless tobacco
GLOBAL YOUTH TOBACCO SURVEY
REPORT GLOBAL YOUTH TOBACCO SURVEY Prepared by: Environmental Health Unit P/ Bag 00269 Gaborone TEL: 3975351 FAX: 3974354 E-mail: tmaule@gov.bw TABLE OF CONTENTS 1 Introduction Background Objectives Rationale
Tobacco and the LGBT Communities. Protect yourself and the people you care about.
Tobacco and the LGBT Communities Protect yourself and the people you care about. Know the facts that can help save your life or the life of someone you love. The facts Tobacco is the leading preventable
Low-Nitrosamine Dissolvable Tobacco Products Star Scientific, Inc. Part III Initiation and Cessation
Low-Nitrosamine Dissolvable Tobacco Products Star Scientific, Inc. Part III Initiation and Cessation Using science to reduce tobacco-related harm at every level of the population 1 Summary - Parts I &
The Essential Guide to the Master Settlement Agreement. June 22, 2015
The Essential Guide to the Master Settlement Agreement June 22, 2015 How to Use Webex If you can hear us through your computer, you do not need to dial into the call. Just adjust your computer speakers
REPORTING INSTRUMENT
REPORTING INSTRUMENT 1. Origin of the report (a) Name of Contracting Party Cambodia (b) Information on National Contact/Focal Point Name and title of contact officer Mailing address Dr Lim Thai Pheang,
Official Gazette of the Republic of Iraq. Contents of No. 4318
Unofficial Translation 1 Presidential decrees Official Gazette of the Republic of Iraq Contents of No. 4318 First amendment to Directive No. 10 of 1997 appointing lawyers and determining their fees Directive
FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality
FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality Lawrence Deyton, M.S.P.H., M.D. Director, FDA Center for Tobacco Products June 11, 2012 FDA s Vision To make tobaccorelated
Burkina Faso. Report card on the WHO Framework Convention on Tobacco Control. 29 October Contents. Introduction
Report card on the WHO Framework Convention on Tobacco Control Burkina Faso Introduction Tobacco use is the single most preventable cause of death in the world today, and is estimated to kill more than